WallStreetZenWallStreetZen

NASDAQ: BNGO
Bionano Genomics Inc Stock

$1.85+0.04 (+2.21%)
Updated Jan 27, 2023
BNGO Price
$1.85
Fair Value Price
$1.91
Market Cap
$549.31M
52 Week Low
$1.16
52 Week High
$4.35
P/E
-4.51x
P/B
1.95x
P/S
20.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.89M
Earnings
-$116.87M
Gross Margin
16.9%
Operating Margin
-471.73%
Profit Margin
-451.4%
Debt to Equity
0.15
Operating Cash Flow
-$116M
Beta
1.13
Next Earnings
Feb 27, 2023
Ex-Dividend
N/A
Next Dividend
N/A

BNGO Overview

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics. In addition, it offers testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; EpiPanelDx PLUS, a genetic testing panel for patients who have experienced seizures, infantile spasms, encephalopathy, or febrile seizures; PGx test, which identifies over 60 alleles in 11 genes. The company was founded in 2003 and is headquartered in San Diego, California.

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BNGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BNGO ($1.85) is undervalued by 3% relative to our estimate of its Fair Value price of $1.91 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BNGO ($1.85) is not significantly undervalued (3%) relative to our estimate of its Fair Value price of $1.91 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BNGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BNGO due diligence checks available for Premium users.

Be the first to know about important BNGO news, forecast changes, insider trades & much more!

BNGO News

Valuation

BNGO fair value

Fair Value of BNGO stock based on Discounted Cash Flow (DCF)
Price
$1.85
Fair Value
$1.91
Undervalued by
3.00%
BNGO ($1.85) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BNGO ($1.85) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BNGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BNGO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.51x
Industry
37.12x
Market
23.59x

BNGO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.95x
Industry
4.46x
BNGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BNGO's financial health

Profit margin

Revenue
$7.2M
Net Income
-$31.8M
Profit Margin
-440.5%
BNGO's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BNGO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$323.7M
Liabilities
$42.0M
Debt to equity
0.15
BNGO's short-term assets ($218.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BNGO's short-term assets ($218.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BNGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$29.5M
Investing
$8.0M
Financing
$22.7M
BNGO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BNGO vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
BNGO$549.31M+2.21%-4.51x1.95x
SENS$530.86M+1.83%2.27x-35.24x
MXCT$588.81M0.00%-25.09x2.31x
OABI$484.24M-2.24%N/A2.13x
NVTA$616.95M+3.25%-0.18x3.88x

Bionano Genomics Stock FAQ

What is Bionano Genomics's quote symbol?

NASDAQ: BNGO) Bionano Genomics trades on the NASDAQ under the ticker symbol BNGO. Bionano Genomics stock quotes can also be displayed as NASDAQ: BNGO.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

What is the 52 week high and low for Bionano Genomics (NASDAQ: BNGO)?

(NASDAQ: BNGO) Bionano Genomics's 52-week high was $4.35, and its 52-week low was $1.16. It is currently -57.47% from its 52-week high and 59.48% from its 52-week low.

How much is Bionano Genomics stock worth today?

(NASDAQ: BNGO) Bionano Genomics currently has 296,924,500 outstanding shares. With Bionano Genomics stock trading at $1.85 per share, the total value of Bionano Genomics stock (market capitalization) is $549.31M.

Bionano Genomics stock was originally listed at a price of $6.15 in Aug 21, 2018. If you had invested in Bionano Genomics stock at $6.15, your return over the last 4 years would have been -69.92%, for an annualized return of -25.94% (not including any dividends or dividend reinvestments).

How much is Bionano Genomics's stock price per share?

(NASDAQ: BNGO) Bionano Genomics stock price per share is $1.85 today (as of Jan 27, 2023).

What is Bionano Genomics's Market Cap?

(NASDAQ: BNGO) Bionano Genomics's market cap is $549.31M, as of Jan 29, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bionano Genomics's market cap is calculated by multiplying BNGO's current stock price of $1.85 by BNGO's total outstanding shares of 296,924,500.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.